Sphere Medical Holding’s Proxima System Receives CE Mark of Approval

Sphere Medical Holding announced that it has received the CE Mark approval to market its patient-attached arterial blood analyzer.

Cambridge-based diagnostics device maker Sphere Medical Holding announced that it has received the CE Mark approval to market its patient-attached arterial blood analyzer, Proxima system.

The Proxima system can be used in intensive care and the operating room to get real-time results of blood gas, hematocrit, and electrolyte measurements as often as necessary rather than sending the blood samples to laboratories for analysis.

Blood Donation - Overview
Blood donation is a process of any consenting adult voluntarily agreeing to have his/her blood drawn for medical use. Know more about blood donation and how you can become a volunteer..

Doctors can attach the system to the arterial line of the patient and tests can be initialized with the help of a touchscreen control panel which will also display the results. The doctors can initiate the test as many times as they want and there are no additional costs associated with each test, with the blood sample returned back into the patient after the test.

Stating that the approval for Proxima marks a major milestone for the company, Sphere Medical’s CEO Wolfgang Rencken said, “A very considerable effort has gone into the CE marking process and today’s announcement of its successful completion represents a significant milestone for the Company and is the beginning of Proxima's commercial future. This is an exciting time for the Company, its partners, investors and staff and I am delighted to have joined at such a pivotal time.”

Source-Medindia

Blood Pressure Screening
Hypertension accounts for nearly 6% of deaths worldwide.

Blood Groups
The blood group of a person is determined by the presence or absence of certain inherited antigenic substances and certain acquired antibodies in blood.